Teddi Mellencamp Gives Update on Brain Cancer Treatment

Teddi Mellencamp says she is doing well while receiving regular immunotherapy and reports that doctors have told her there is "no trace of cancer" despite being classified as stage 4.

Teddi Mellencamp says she is doing well while continuing treatment for stage 4 cancer and told PEOPLE that "things are moving along nicely." She reported having immunotherapy two weeks ago and said another session is scheduled in two weeks. Mellencamp was first diagnosed with melanoma in 2022 and later told reporters that the disease had spread to her brain and lungs. Earlier this month a new medication caused a serious reaction that required a short hospital stay, and her symptoms later improved. Key details: - Mellencamp was diagnosed with melanoma in 2022 and underwent multiple surgeries. - In April 2025 she announced the cancer had metastasized to her brain and lungs. - She has undergone a series of surgeries, reported as 17 in total. - Mellencamp has been receiving regular immunotherapy and said she had a treatment two weeks ago. - She said another immunotherapy session is scheduled in two weeks. - Earlier this month a new medication triggered Stevens-Johnson Syndrome and led to a brief hospitalization; her symptoms improved. Summary: Mellencamp reports ongoing immunotherapy with a planned treatment in two weeks and says doctors have told her there is "no trace of cancer" even though she remains classified as stage 4. The immediate next step noted in her update is the scheduled immunotherapy session.